Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MDGL

Madrigal Pharmaceuticals

$131.53

-14.46 (-9.90%)

08:10
02/09/18
02/09
08:10
02/09/18
08:10
Recommendations
Madrigal Pharmaceuticals analyst commentary at Roth Capital »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$145.99

-0.66 (-0.45%)

13:02
02/08/18
02/08
13:02
02/08/18
13:02
Recommendations
Madrigal Pharmaceuticals analyst commentary at H.C. Wainwright »

Madrigal Phase 2 trial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$145.99

-0.66 (-0.45%)

10:26
02/08/18
02/08
10:26
02/08/18
10:26
Recommendations
Madrigal Pharmaceuticals analyst commentary at Evercore ISI »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$145.99

-0.66 (-0.45%)

06:55
02/08/18
02/08
06:55
02/08/18
06:55
Hot Stocks
Madrigal Pharmaceuticals' MGL-3196 achieves primary endpoint in trial »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$81.73

-1.76 (-2.11%)

, BIIB

Biogen

$343.83

-2.17 (-0.63%)

14:23
02/05/18
02/05
14:23
02/05/18
14:23
Earnings
On The Fly: What to watch in biotech earnings reports »

The earnings season for…

GILD

Gilead

$81.73

-1.76 (-2.11%)

BIIB

Biogen

$343.83

-2.17 (-0.63%)

AMGN

Amgen

$187.01

1.45 (0.78%)

CELG

Celgene

$99.80

-0.54 (-0.54%)

ALNY

Alnylam

$124.50

-4.93 (-3.81%)

ONCE

Spark Therapeutics

$55.87

-0.43 (-0.76%)

SCMP

Sucampo

$17.95

-0.025 (-0.14%)

MDGL

Madrigal Pharmaceuticals

$147.99

-1.05 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 06

    Feb

  • 12

    Feb

  • 12

    Feb

  • 12

    Feb

  • 16

    Feb

  • 26

    Feb

  • 08

    Mar

  • 25

    Mar

  • 23

    Apr

  • 30

    Apr

  • 17

    May

  • 28

    May

  • 30

    May

MDGL

Madrigal Pharmaceuticals

$126.24

4.44 (3.65%)

07:07
01/30/18
01/30
07:07
01/30/18
07:07
Recommendations
Madrigal Pharmaceuticals analyst commentary at H.C. Wainwright »

Madrigal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
MDGL

Madrigal Pharmaceuticals

$84.04

1.57 (1.90%)

06:23
12/19/17
12/19
06:23
12/19/17
06:23
Syndicate
Madrigal Pharmaceuticals 1.5M share Secondary priced at $83.00 »

Goldman Sachs acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

MDGL

Madrigal Pharmaceuticals

$82.47

4.79 (6.17%)

07:19
12/18/17
12/18
07:19
12/18/17
07:19
Syndicate
Madrigal Pharmaceuticals files to sell $100M of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$81.57

-0.8 (-0.97%)

08:17
12/11/17
12/11
08:17
12/11/17
08:17
Recommendations
Madrigal Pharmaceuticals analyst commentary at Roth Capital »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$87.18

40.88 (88.29%)

09:29
12/07/17
12/07
09:29
12/07/17
09:29
Recommendations
Madrigal Pharmaceuticals analyst commentary at Evercore ISI »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.